nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—STK10—renal vein—nephrolithiasis	0.0506	0.0915	CbGeAlD
Bosutinib—STK10—renal artery—nephrolithiasis	0.034	0.0615	CbGeAlD
Bosutinib—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00929	0.0582	CcSEcCtD
Bosutinib—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00777	0.0487	CcSEcCtD
Bosutinib—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0394	CcSEcCtD
Bosutinib—TLK1—renal system—nephrolithiasis	0.00612	0.0111	CbGeAlD
Bosutinib—SIK2—renal system—nephrolithiasis	0.00595	0.0108	CbGeAlD
Bosutinib—VRK2—nephron tubule—nephrolithiasis	0.00584	0.0106	CbGeAlD
Bosutinib—FRK—renal system—nephrolithiasis	0.0058	0.0105	CbGeAlD
Bosutinib—TLK1—cortex of kidney—nephrolithiasis	0.00576	0.0104	CbGeAlD
Bosutinib—PRKCQ—cortex of kidney—nephrolithiasis	0.00568	0.0103	CbGeAlD
Bosutinib—CLK3—renal system—nephrolithiasis	0.00566	0.0102	CbGeAlD
Bosutinib—STK26—nephron tubule—nephrolithiasis	0.00562	0.0102	CbGeAlD
Bosutinib—SRMS—renal system—nephrolithiasis	0.00541	0.0098	CbGeAlD
Bosutinib—WEE1—nephron tubule—nephrolithiasis	0.00538	0.00974	CbGeAlD
Bosutinib—DSTYK—cortex of kidney—nephrolithiasis	0.00533	0.00965	CbGeAlD
Bosutinib—CLK3—cortex of kidney—nephrolithiasis	0.00533	0.00965	CbGeAlD
Bosutinib—SRMS—kidney—nephrolithiasis	0.00523	0.00947	CbGeAlD
Bosutinib—SYK—renal system—nephrolithiasis	0.0052	0.00942	CbGeAlD
Bosutinib—CDK2—renal system—nephrolithiasis	0.00515	0.00933	CbGeAlD
Bosutinib—EIF2AK1—cortex of kidney—nephrolithiasis	0.00515	0.00933	CbGeAlD
Bosutinib—STK25—nephron tubule—nephrolithiasis	0.00514	0.0093	CbGeAlD
Bosutinib—STK26—renal system—nephrolithiasis	0.00511	0.00924	CbGeAlD
Bosutinib—SYK—kidney—nephrolithiasis	0.00503	0.0091	CbGeAlD
Bosutinib—VRK2—cortex of kidney—nephrolithiasis	0.00499	0.00904	CbGeAlD
Bosutinib—CDK2—kidney—nephrolithiasis	0.00498	0.00902	CbGeAlD
Bosutinib—SIK3—nephron tubule—nephrolithiasis	0.00496	0.00898	CbGeAlD
Bosutinib—STK26—kidney—nephrolithiasis	0.00494	0.00893	CbGeAlD
Bosutinib—SYK—cortex of kidney—nephrolithiasis	0.0049	0.00887	CbGeAlD
Bosutinib—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00488	0.0306	CcSEcCtD
Bosutinib—STK26—cortex of kidney—nephrolithiasis	0.00481	0.0087	CbGeAlD
Bosutinib—STK25—renal system—nephrolithiasis	0.00467	0.00845	CbGeAlD
Bosutinib—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00464	0.0291	CcSEcCtD
Bosutinib—WEE1—cortex of kidney—nephrolithiasis	0.0046	0.00834	CbGeAlD
Bosutinib—DMPK—cortex of kidney—nephrolithiasis	0.0046	0.00834	CbGeAlD
Bosutinib—PLK2—renal system—nephrolithiasis	0.00454	0.00822	CbGeAlD
Bosutinib—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00448	0.0281	CcSEcCtD
Bosutinib—STK25—cortex of kidney—nephrolithiasis	0.0044	0.00796	CbGeAlD
Bosutinib—PLK2—kidney—nephrolithiasis	0.00439	0.00795	CbGeAlD
Bosutinib—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00435	0.0272	CcSEcCtD
Bosutinib—PLK2—cortex of kidney—nephrolithiasis	0.00428	0.00774	CbGeAlD
Bosutinib—SIK3—cortex of kidney—nephrolithiasis	0.00425	0.00769	CbGeAlD
Bosutinib—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00424	0.0266	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00418	0.0262	CcSEcCtD
Bosutinib—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00411	0.0257	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00409	0.0256	CcSEcCtD
Bosutinib—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00401	0.0251	CcSEcCtD
Bosutinib—STK24—cortex of kidney—nephrolithiasis	0.00399	0.00723	CbGeAlD
Bosutinib—MAP4K4—nephron tubule—nephrolithiasis	0.00389	0.00705	CbGeAlD
Bosutinib—NUAK2—nephron tubule—nephrolithiasis	0.00387	0.007	CbGeAlD
Bosutinib—BCR—nephron tubule—nephrolithiasis	0.00387	0.007	CbGeAlD
Bosutinib—FER—cortex of kidney—nephrolithiasis	0.00386	0.00699	CbGeAlD
Bosutinib—ROCK1—renal system—nephrolithiasis	0.00379	0.00685	CbGeAlD
Bosutinib—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00375	0.0235	CcSEcCtD
Bosutinib—CSK—nephron tubule—nephrolithiasis	0.00374	0.00676	CbGeAlD
Bosutinib—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00373	0.0234	CcSEcCtD
Bosutinib—CSNK1A1—nephron tubule—nephrolithiasis	0.00371	0.00672	CbGeAlD
Bosutinib—CLK1—nephron tubule—nephrolithiasis	0.00369	0.00667	CbGeAlD
Bosutinib—BMPR2—renal system—nephrolithiasis	0.00368	0.00666	CbGeAlD
Bosutinib—ROCK1—kidney—nephrolithiasis	0.00366	0.00662	CbGeAlD
Bosutinib—ERBB4—cortex of kidney—nephrolithiasis	0.00361	0.00654	CbGeAlD
Bosutinib—STK3—cortex of kidney—nephrolithiasis	0.00361	0.00654	CbGeAlD
Bosutinib—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0225	CcSEcCtD
Bosutinib—BMPR2—kidney—nephrolithiasis	0.00355	0.00643	CbGeAlD
Bosutinib—MAP4K4—renal system—nephrolithiasis	0.00354	0.00641	CbGeAlD
Bosutinib—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00352	0.022	CcSEcCtD
Bosutinib—BCR—renal system—nephrolithiasis	0.00351	0.00636	CbGeAlD
Bosutinib—BMPR2—cortex of kidney—nephrolithiasis	0.00346	0.00627	CbGeAlD
Bosutinib—STK36—cortex of kidney—nephrolithiasis	0.00343	0.00622	CbGeAlD
Bosutinib—MAP4K4—kidney—nephrolithiasis	0.00342	0.00619	CbGeAlD
Bosutinib—MAP2K1—renal system—nephrolithiasis	0.00342	0.00619	CbGeAlD
Bosutinib—CSK—renal system—nephrolithiasis	0.0034	0.00615	CbGeAlD
Bosutinib—SIK1—nephron tubule—nephrolithiasis	0.00339	0.00613	CbGeAlD
Bosutinib—CSNK1A1—renal system—nephrolithiasis	0.00337	0.00611	CbGeAlD
Bosutinib—CLK1—renal system—nephrolithiasis	0.00335	0.00607	CbGeAlD
Bosutinib—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00334	0.0209	CcSEcCtD
Bosutinib—ERBB3—nephron tubule—nephrolithiasis	0.00332	0.00601	CbGeAlD
Bosutinib—NUAK2—cortex of kidney—nephrolithiasis	0.00331	0.00599	CbGeAlD
Bosutinib—BCR—cortex of kidney—nephrolithiasis	0.00331	0.00599	CbGeAlD
Bosutinib—MAP2K1—kidney—nephrolithiasis	0.0033	0.00598	CbGeAlD
Bosutinib—MAP3K2—nephron tubule—nephrolithiasis	0.00329	0.00595	CbGeAlD
Bosutinib—CSK—kidney—nephrolithiasis	0.00328	0.00594	CbGeAlD
Bosutinib—CSNK1A1—kidney—nephrolithiasis	0.00326	0.0059	CbGeAlD
Bosutinib—LRRK2—renal system—nephrolithiasis	0.00326	0.0059	CbGeAlD
Bosutinib—CLK1—kidney—nephrolithiasis	0.00324	0.00587	CbGeAlD
Bosutinib—PTK2—nephron tubule—nephrolithiasis	0.00322	0.00583	CbGeAlD
Bosutinib—TBK1—nephron tubule—nephrolithiasis	0.00322	0.00583	CbGeAlD
Bosutinib—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00321	0.0201	CcSEcCtD
Bosutinib—CSK—cortex of kidney—nephrolithiasis	0.0032	0.00579	CbGeAlD
Bosutinib—PTK2B—renal system—nephrolithiasis	0.00318	0.00575	CbGeAlD
Bosutinib—CSNK1A1—cortex of kidney—nephrolithiasis	0.00318	0.00575	CbGeAlD
Bosutinib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00316	0.0198	CcSEcCtD
Bosutinib—CLK1—cortex of kidney—nephrolithiasis	0.00316	0.00571	CbGeAlD
Bosutinib—IRAK1—nephron tubule—nephrolithiasis	0.00316	0.00571	CbGeAlD
Bosutinib—LRRK2—kidney—nephrolithiasis	0.00315	0.00571	CbGeAlD
Bosutinib—CAMK2G—cortex of kidney—nephrolithiasis	0.0031	0.00561	CbGeAlD
Bosutinib—SIK1—renal system—nephrolithiasis	0.00308	0.00557	CbGeAlD
Bosutinib—PTK2B—kidney—nephrolithiasis	0.00307	0.00556	CbGeAlD
Bosutinib—LRRK2—cortex of kidney—nephrolithiasis	0.00307	0.00556	CbGeAlD
Bosutinib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00304	0.019	CcSEcCtD
Bosutinib—ERBB3—renal system—nephrolithiasis	0.00302	0.00546	CbGeAlD
Bosutinib—MAP2K2—renal system—nephrolithiasis	0.00301	0.00545	CbGeAlD
Bosutinib—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00299	0.0188	CcSEcCtD
Bosutinib—SIK1—kidney—nephrolithiasis	0.00298	0.00539	CbGeAlD
Bosutinib—SLK—nephron tubule—nephrolithiasis	0.00295	0.00534	CbGeAlD
Bosutinib—CSNK1E—cortex of kidney—nephrolithiasis	0.00294	0.00533	CbGeAlD
Bosutinib—EPHB4—nephron tubule—nephrolithiasis	0.00293	0.0053	CbGeAlD
Bosutinib—TBK1—renal system—nephrolithiasis	0.00293	0.0053	CbGeAlD
Bosutinib—PTK2—renal system—nephrolithiasis	0.00293	0.0053	CbGeAlD
Bosutinib—ERBB3—kidney—nephrolithiasis	0.00292	0.00528	CbGeAlD
Bosutinib—MAP2K2—kidney—nephrolithiasis	0.00291	0.00527	CbGeAlD
Bosutinib—SIK1—cortex of kidney—nephrolithiasis	0.0029	0.00524	CbGeAlD
Bosutinib—CYP3A4—urine—nephrolithiasis	0.00288	0.00522	CbGeAlD
Bosutinib—EPHA2—nephron tubule—nephrolithiasis	0.00287	0.0052	CbGeAlD
Bosutinib—FYN—nephron tubule—nephrolithiasis	0.00287	0.00519	CbGeAlD
Bosutinib—MAP2K2—cortex of kidney—nephrolithiasis	0.00283	0.00513	CbGeAlD
Bosutinib—ULK3—cortex of kidney—nephrolithiasis	0.00283	0.00513	CbGeAlD
Bosutinib—TBK1—kidney—nephrolithiasis	0.00283	0.00512	CbGeAlD
Bosutinib—PTK2—kidney—nephrolithiasis	0.00283	0.00512	CbGeAlD
Bosutinib—RPS6KB1—renal system—nephrolithiasis	0.00281	0.00509	CbGeAlD
Bosutinib—MAP3K3—nephron tubule—nephrolithiasis	0.0028	0.00507	CbGeAlD
Bosutinib—MAP3K7—cortex of kidney—nephrolithiasis	0.00279	0.00504	CbGeAlD
Bosutinib—TBK1—cortex of kidney—nephrolithiasis	0.00275	0.00499	CbGeAlD
Bosutinib—PTK2—cortex of kidney—nephrolithiasis	0.00275	0.00499	CbGeAlD
Bosutinib—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00274	0.0171	CcSEcCtD
Bosutinib—RPS6KB1—kidney—nephrolithiasis	0.00272	0.00493	CbGeAlD
Bosutinib—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0027	0.0169	CcSEcCtD
Bosutinib—IRAK1—cortex of kidney—nephrolithiasis	0.0027	0.00489	CbGeAlD
Bosutinib—EPHB4—renal system—nephrolithiasis	0.00266	0.00482	CbGeAlD
Bosutinib—RPS6KB1—cortex of kidney—nephrolithiasis	0.00265	0.0048	CbGeAlD
Bosutinib—AXL—cortex of kidney—nephrolithiasis	0.00262	0.00475	CbGeAlD
Bosutinib—FYN—renal system—nephrolithiasis	0.00261	0.00472	CbGeAlD
Bosutinib—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00259	0.0162	CcSEcCtD
Bosutinib—YES1—nephron tubule—nephrolithiasis	0.00259	0.00469	CbGeAlD
Bosutinib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00258	0.0162	CcSEcCtD
Bosutinib—EPHB4—kidney—nephrolithiasis	0.00257	0.00466	CbGeAlD
Bosutinib—TAOK3—nephron tubule—nephrolithiasis	0.00256	0.00463	CbGeAlD
Bosutinib—SLK—cortex of kidney—nephrolithiasis	0.00253	0.00457	CbGeAlD
Bosutinib—FYN—kidney—nephrolithiasis	0.00252	0.00456	CbGeAlD
Bosutinib—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00252	0.0158	CcSEcCtD
Bosutinib—EPHB4—cortex of kidney—nephrolithiasis	0.00251	0.00454	CbGeAlD
Bosutinib—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0025	0.0157	CcSEcCtD
Bosutinib—FYN—cortex of kidney—nephrolithiasis	0.00246	0.00444	CbGeAlD
Bosutinib—Cough—Hydrochlorothiazide—nephrolithiasis	0.00244	0.0153	CcSEcCtD
Bosutinib—MAP3K3—cortex of kidney—nephrolithiasis	0.0024	0.00434	CbGeAlD
Bosutinib—MAP4K5—cortex of kidney—nephrolithiasis	0.0024	0.00434	CbGeAlD
Bosutinib—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00238	0.0149	CcSEcCtD
Bosutinib—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00238	0.0149	CcSEcCtD
Bosutinib—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00238	0.0149	CcSEcCtD
Bosutinib—YES1—renal system—nephrolithiasis	0.00235	0.00426	CbGeAlD
Bosutinib—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00235	0.0147	CcSEcCtD
Bosutinib—STK10—renal system—nephrolithiasis	0.00233	0.00422	CbGeAlD
Bosutinib—TAOK3—renal system—nephrolithiasis	0.00232	0.00421	CbGeAlD
Bosutinib—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00228	0.0143	CcSEcCtD
Bosutinib—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00228	0.0143	CcSEcCtD
Bosutinib—YES1—kidney—nephrolithiasis	0.00228	0.00412	CbGeAlD
Bosutinib—SRC—renal system—nephrolithiasis	0.00226	0.0041	CbGeAlD
Bosutinib—STK10—kidney—nephrolithiasis	0.00225	0.00408	CbGeAlD
Bosutinib—TAOK3—kidney—nephrolithiasis	0.00225	0.00407	CbGeAlD
Bosutinib—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00223	0.014	CcSEcCtD
Bosutinib—YES1—cortex of kidney—nephrolithiasis	0.00222	0.00401	CbGeAlD
Bosutinib—SRC—kidney—nephrolithiasis	0.00219	0.00396	CbGeAlD
Bosutinib—TAOK3—cortex of kidney—nephrolithiasis	0.00219	0.00396	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00208	0.013	CcSEcCtD
Bosutinib—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0127	CcSEcCtD
Bosutinib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00198	0.0124	CcSEcCtD
Bosutinib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00197	0.0123	CcSEcCtD
Bosutinib—MAP2K5—cortex of kidney—nephrolithiasis	0.00196	0.00355	CbGeAlD
Bosutinib—Pain—Hydrochlorothiazide—nephrolithiasis	0.00195	0.0122	CcSEcCtD
Bosutinib—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00188	0.0118	CcSEcCtD
Bosutinib—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00187	0.0117	CcSEcCtD
Bosutinib—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00181	0.0114	CcSEcCtD
Bosutinib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0018	0.0113	CcSEcCtD
Bosutinib—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0018	0.0113	CcSEcCtD
Bosutinib—PDGFRB—renal system—nephrolithiasis	0.0018	0.00326	CbGeAlD
Bosutinib—ABL1—nephron tubule—nephrolithiasis	0.00177	0.0032	CbGeAlD
Bosutinib—PDGFRB—kidney—nephrolithiasis	0.00174	0.00315	CbGeAlD
Bosutinib—PDGFRB—cortex of kidney—nephrolithiasis	0.0017	0.00307	CbGeAlD
Bosutinib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00164	0.0103	CcSEcCtD
Bosutinib—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0101	CcSEcCtD
Bosutinib—ABL1—renal system—nephrolithiasis	0.00161	0.00291	CbGeAlD
Bosutinib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00978	CcSEcCtD
Bosutinib—ABL1—kidney—nephrolithiasis	0.00155	0.00281	CbGeAlD
Bosutinib—ABL1—cortex of kidney—nephrolithiasis	0.00151	0.00274	CbGeAlD
Bosutinib—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00151	0.00945	CcSEcCtD
Bosutinib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00145	0.00909	CcSEcCtD
Bosutinib—Rash—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00901	CcSEcCtD
Bosutinib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00144	0.009	CcSEcCtD
Bosutinib—Headache—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00895	CcSEcCtD
Bosutinib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00135	0.00849	CcSEcCtD
Bosutinib—CYP3A4—renal system—nephrolithiasis	0.000706	0.00128	CbGeAlD
Bosutinib—CYP3A4—kidney—nephrolithiasis	0.000682	0.00124	CbGeAlD
Bosutinib—ABCB1—nephron tubule—nephrolithiasis	0.00055	0.000995	CbGeAlD
Bosutinib—ABCB1—renal system—nephrolithiasis	0.0005	0.000904	CbGeAlD
Bosutinib—ABCB1—kidney—nephrolithiasis	0.000483	0.000874	CbGeAlD
Bosutinib—ABCB1—cortex of kidney—nephrolithiasis	0.00047	0.000852	CbGeAlD
Bosutinib—FER—Signaling Pathways—CHRM3—nephrolithiasis	0.000361	0.00125	CbGpPWpGaD
Bosutinib—MAP2K2—BDNF signaling pathway—SPP1—nephrolithiasis	0.000356	0.00124	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—DGKH—nephrolithiasis	0.000354	0.00123	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling by GPCR—PTH—nephrolithiasis	0.000353	0.00123	CbGpPWpGaD
Bosutinib—ERBB4—Disease—SLC26A1—nephrolithiasis	0.000353	0.00123	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—ADCY10—nephrolithiasis	0.000351	0.00122	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—ADCY10—nephrolithiasis	0.000351	0.00122	CbGpPWpGaD
Bosutinib—MAP2K1—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.000343	0.00119	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—CHRM3—nephrolithiasis	0.000342	0.00119	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—ADCY10—nephrolithiasis	0.000338	0.00117	CbGpPWpGaD
Bosutinib—FYN—BDNF signaling pathway—SPP1—nephrolithiasis	0.000335	0.00116	CbGpPWpGaD
Bosutinib—HCK—Disease—ATP6V0A4—nephrolithiasis	0.000334	0.00116	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—RGS14—nephrolithiasis	0.000333	0.00116	CbGpPWpGaD
Bosutinib—MAP2K1—BDNF signaling pathway—SPP1—nephrolithiasis	0.000333	0.00116	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—PTH—nephrolithiasis	0.00033	0.00115	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—RGS14—nephrolithiasis	0.000326	0.00113	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—CHRM3—nephrolithiasis	0.000326	0.00113	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—DGKH—nephrolithiasis	0.000321	0.00112	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000321	0.00112	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—RGS14—nephrolithiasis	0.000321	0.00112	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—DGKH—nephrolithiasis	0.000316	0.0011	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000316	0.0011	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000316	0.0011	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—DGKH—nephrolithiasis	0.000316	0.0011	CbGpPWpGaD
Bosutinib—ERBB4—Disease—ATP6V0A4—nephrolithiasis	0.000315	0.00109	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—PTH—nephrolithiasis	0.000313	0.00109	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—CHRM3—nephrolithiasis	0.000313	0.00109	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—RGS14—nephrolithiasis	0.000312	0.00108	CbGpPWpGaD
Bosutinib—ERBB3—Disease—SLC26A1—nephrolithiasis	0.000311	0.00108	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—RGS14—nephrolithiasis	0.00031	0.00108	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—SLC7A9—nephrolithiasis	0.000307	0.00107	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—DGKH—nephrolithiasis	0.000307	0.00107	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000305	0.00106	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—DGKH—nephrolithiasis	0.000305	0.00106	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—ADCY10—nephrolithiasis	0.000301	0.00105	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—RGS14—nephrolithiasis	0.000298	0.00104	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—PTH—nephrolithiasis	0.000298	0.00104	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—RGS14—nephrolithiasis	0.000298	0.00104	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—ADCY10—nephrolithiasis	0.000297	0.00103	CbGpPWpGaD
Bosutinib—EGFR—Direct p53 effectors—SPP1—nephrolithiasis	0.000296	0.00103	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by PDGF—SPP1—nephrolithiasis	0.000295	0.00103	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by PDGF—SPP1—nephrolithiasis	0.000288	0.001	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—RGS14—nephrolithiasis	0.000288	0.000999	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—PTH—nephrolithiasis	0.000286	0.000993	CbGpPWpGaD
Bosutinib—MAP2K2—Focal Adhesion—SPP1—nephrolithiasis	0.000285	0.000991	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000282	0.000979	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000282	0.000978	CbGpPWpGaD
Bosutinib—PDGFRB—Focal Adhesion—SPP1—nephrolithiasis	0.000278	0.000967	CbGpPWpGaD
Bosutinib—FYN—Signaling by PDGF—SPP1—nephrolithiasis	0.000278	0.000965	CbGpPWpGaD
Bosutinib—ERBB3—Disease—ATP6V0A4—nephrolithiasis	0.000277	0.000963	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by PDGF—SPP1—nephrolithiasis	0.000276	0.000959	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—CHRM3—nephrolithiasis	0.000273	0.000949	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000272	0.000945	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000272	0.000945	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—SLC7A9—nephrolithiasis	0.000272	0.000945	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—DGKH—nephrolithiasis	0.000272	0.000945	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—RGS14—nephrolithiasis	0.000271	0.000941	CbGpPWpGaD
Bosutinib—FYN—Focal Adhesion—SPP1—nephrolithiasis	0.000268	0.000932	CbGpPWpGaD
Bosutinib—MAP2K1—Focal Adhesion—SPP1—nephrolithiasis	0.000267	0.000927	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—ADCY10—nephrolithiasis	0.000265	0.000921	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000264	0.000916	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—PTH—nephrolithiasis	0.000258	0.000895	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000256	0.000889	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—RGS14—nephrolithiasis	0.000256	0.000889	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000255	0.000885	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—DGKH—nephrolithiasis	0.000255	0.000885	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—RGS14—nephrolithiasis	0.000252	0.000877	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—PTH—nephrolithiasis	0.00025	0.000868	CbGpPWpGaD
Bosutinib—SRC—BDNF signaling pathway—SPP1—nephrolithiasis	0.000247	0.000857	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000243	0.000843	CbGpPWpGaD
Bosutinib—EGFR—Signaling by PDGF—SPP1—nephrolithiasis	0.00024	0.000833	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—RGS14—nephrolithiasis	0.000239	0.000831	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—PTH—nephrolithiasis	0.000234	0.000813	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—SPP1—nephrolithiasis	0.000232	0.000807	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—CHRM3—nephrolithiasis	0.000232	0.000807	CbGpPWpGaD
Bosutinib—EGFR—Focal Adhesion—SPP1—nephrolithiasis	0.000232	0.000805	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—ADCY10—nephrolithiasis	0.000232	0.000805	CbGpPWpGaD
Bosutinib—LCK—Signaling by PDGF—SPP1—nephrolithiasis	0.000231	0.000803	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—CHRM3—nephrolithiasis	0.000228	0.000792	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—CHRM3—nephrolithiasis	0.000228	0.000792	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—ADCY10—nephrolithiasis	0.000226	0.000785	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—RGS14—nephrolithiasis	0.000225	0.000783	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—DGKH—nephrolithiasis	0.000225	0.000782	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000222	0.000771	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000222	0.000771	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—ADCY10—nephrolithiasis	0.000221	0.000769	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—DGKH—nephrolithiasis	0.00022	0.000765	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00022	0.000765	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—CHRM3—nephrolithiasis	0.00022	0.000765	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—ADCY10—nephrolithiasis	0.000218	0.000757	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000217	0.000754	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—DGKH—nephrolithiasis	0.000217	0.000754	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—ADCY10—nephrolithiasis	0.000217	0.000753	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—SLC26A1—nephrolithiasis	0.000213	0.00074	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—PTH—nephrolithiasis	0.000213	0.000738	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—DGKH—nephrolithiasis	0.000211	0.000732	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000209	0.000726	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—DGKH—nephrolithiasis	0.000209	0.000726	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—PTH—nephrolithiasis	0.000209	0.000725	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—PTH—nephrolithiasis	0.000209	0.000725	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—SLC26A1—nephrolithiasis	0.000208	0.000723	CbGpPWpGaD
Bosutinib—SRC—Signaling by PDGF—SPP1—nephrolithiasis	0.000205	0.000711	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—DGKH—nephrolithiasis	0.000202	0.0007	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000202	0.0007	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—PTH—nephrolithiasis	0.000202	0.0007	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000202	0.0007	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—DGKH—nephrolithiasis	0.000202	0.0007	CbGpPWpGaD
Bosutinib—FYN—Disease—SLC26A1—nephrolithiasis	0.000201	0.000696	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—SLC26A1—nephrolithiasis	0.000199	0.000693	CbGpPWpGaD
Bosutinib—SRC—Focal Adhesion—SPP1—nephrolithiasis	0.000198	0.000687	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—SPP1—nephrolithiasis	0.000198	0.000686	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—RGS14—nephrolithiasis	0.000197	0.000684	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000194	0.000675	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—DGKH—nephrolithiasis	0.000194	0.000675	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—RGS14—nephrolithiasis	0.000192	0.000668	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—ATP6V0A4—nephrolithiasis	0.00019	0.00066	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ADCY10—nephrolithiasis	0.000188	0.000654	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—RGS14—nephrolithiasis	0.000188	0.000654	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—ATP6V0A4—nephrolithiasis	0.000185	0.000644	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—RGS14—nephrolithiasis	0.000185	0.000644	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—RGS14—nephrolithiasis	0.000184	0.00064	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—CHRM3—nephrolithiasis	0.000184	0.00064	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—DGKH—nephrolithiasis	0.000183	0.000636	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ADCY10—nephrolithiasis	0.000181	0.00063	CbGpPWpGaD
Bosutinib—FYN—Disease—ATP6V0A4—nephrolithiasis	0.000179	0.000621	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—ATP6V0A4—nephrolithiasis	0.000178	0.000617	CbGpPWpGaD
Bosutinib—EGFR—Disease—SLC26A1—nephrolithiasis	0.000173	0.000602	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000173	0.0006	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—DGKH—nephrolithiasis	0.000173	0.0006	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00017	0.000592	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—DGKH—nephrolithiasis	0.00017	0.000592	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—PTH—nephrolithiasis	0.000169	0.000585	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000168	0.000584	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000168	0.000584	CbGpPWpGaD
Bosutinib—LCK—Disease—SLC26A1—nephrolithiasis	0.000167	0.00058	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—SPP1—nephrolithiasis	0.000166	0.000575	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000163	0.000566	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000162	0.000562	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—DGKH—nephrolithiasis	0.000162	0.000562	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADCY10—nephrolithiasis	0.000161	0.000558	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RGS14—nephrolithiasis	0.00016	0.000556	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CHRM3—nephrolithiasis	0.000159	0.000553	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—SPP1—nephrolithiasis	0.000157	0.000545	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000157	0.000545	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000156	0.000543	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000156	0.000543	CbGpPWpGaD
Bosutinib—EGFR—Disease—ATP6V0A4—nephrolithiasis	0.000154	0.000536	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RGS14—nephrolithiasis	0.000154	0.000536	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000152	0.000529	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—DGKH—nephrolithiasis	0.000152	0.000529	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000152	0.000529	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000151	0.000525	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—SPP1—nephrolithiasis	0.00015	0.00052	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—PTH—nephrolithiasis	0.000149	0.000517	CbGpPWpGaD
Bosutinib—LCK—Disease—ATP6V0A4—nephrolithiasis	0.000149	0.000517	CbGpPWpGaD
Bosutinib—SRC—Disease—SLC26A1—nephrolithiasis	0.000148	0.000513	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000146	0.000506	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—PTH—nephrolithiasis	0.000146	0.000506	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CHRM3—nephrolithiasis	0.000146	0.000506	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—SPP1—nephrolithiasis	0.000144	0.000499	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—PTH—nephrolithiasis	0.000144	0.000499	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CHRM3—nephrolithiasis	0.00014	0.000488	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000139	0.000484	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000139	0.000484	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—PTH—nephrolithiasis	0.000139	0.000484	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—PTH—nephrolithiasis	0.000138	0.00048	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RGS14—nephrolithiasis	0.000137	0.000474	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—PTH—nephrolithiasis	0.000133	0.000463	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—PTH—nephrolithiasis	0.000133	0.000463	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000133	0.000462	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—DGKH—nephrolithiasis	0.000133	0.000462	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CHRM3—nephrolithiasis	0.000132	0.00046	CbGpPWpGaD
Bosutinib—SRC—Disease—ATP6V0A4—nephrolithiasis	0.000132	0.000458	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00013	0.000451	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—DGKH—nephrolithiasis	0.00013	0.000451	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—PTH—nephrolithiasis	0.000128	0.000446	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000127	0.000442	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—DGKH—nephrolithiasis	0.000127	0.000442	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—SPP1—nephrolithiasis	0.000125	0.000436	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—DGKH—nephrolithiasis	0.000125	0.000435	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000125	0.000435	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CHRM3—nephrolithiasis	0.000125	0.000434	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000124	0.000432	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—DGKH—nephrolithiasis	0.000124	0.000432	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CHRM3—nephrolithiasis	0.000123	0.000428	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—PTH—nephrolithiasis	0.000121	0.00042	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000117	0.000406	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—PTH—nephrolithiasis	0.000114	0.000397	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—PTH—nephrolithiasis	0.000113	0.000392	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000111	0.000387	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CHRM3—nephrolithiasis	0.00011	0.000382	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DGKH—nephrolithiasis	0.000108	0.000376	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000108	0.000376	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—PTH—nephrolithiasis	0.000107	0.000371	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—SPP1—nephrolithiasis	0.000107	0.000371	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—SPP1—nephrolithiasis	0.000105	0.000364	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—SPP1—nephrolithiasis	0.000105	0.000364	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DGKH—nephrolithiasis	0.000104	0.000362	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000104	0.000362	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—SPP1—nephrolithiasis	0.000101	0.000351	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—PTH—nephrolithiasis	0.000101	0.00035	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GRHPR—nephrolithiasis	9.66e-05	0.000336	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CHRM3—nephrolithiasis	9.62e-05	0.000334	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CHRM3—nephrolithiasis	9.39e-05	0.000326	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ATP6V0A4—nephrolithiasis	9.22e-05	0.00032	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DGKH—nephrolithiasis	9.22e-05	0.00032	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CHRM3—nephrolithiasis	9.19e-05	0.000319	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CHRM3—nephrolithiasis	9.05e-05	0.000314	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CHRM3—nephrolithiasis	9e-05	0.000313	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—PTH—nephrolithiasis	8.8e-05	0.000306	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AGXT—nephrolithiasis	8.61e-05	0.000299	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—PTH—nephrolithiasis	8.59e-05	0.000298	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—SPP1—nephrolithiasis	8.46e-05	0.000294	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PTH—nephrolithiasis	8.41e-05	0.000292	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PTH—nephrolithiasis	8.28e-05	0.000287	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PTH—nephrolithiasis	8.23e-05	0.000286	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CHRM3—nephrolithiasis	7.82e-05	0.000272	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CHRM3—nephrolithiasis	7.53e-05	0.000262	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SLC26A1—nephrolithiasis	7.32e-05	0.000254	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APRT—nephrolithiasis	7.32e-05	0.000254	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—SPP1—nephrolithiasis	7.31e-05	0.000254	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—SPP1—nephrolithiasis	7.21e-05	0.00025	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PTH—nephrolithiasis	7.15e-05	0.000248	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—SPP1—nephrolithiasis	6.94e-05	0.000241	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PTH—nephrolithiasis	6.89e-05	0.000239	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SPP1—nephrolithiasis	6.69e-05	0.000232	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SPP1—nephrolithiasis	6.69e-05	0.000232	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CHRM3—nephrolithiasis	6.67e-05	0.000232	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SPP1—nephrolithiasis	6.45e-05	0.000224	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PTH—nephrolithiasis	6.1e-05	0.000212	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GRHPR—nephrolithiasis	5.95e-05	0.000207	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SPP1—nephrolithiasis	5.74e-05	0.000199	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SPP1—nephrolithiasis	5.66e-05	0.000197	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SPP1—nephrolithiasis	5.37e-05	0.000186	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AGXT—nephrolithiasis	5.31e-05	0.000184	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AQP1—nephrolithiasis	5.22e-05	0.000181	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SPP1—nephrolithiasis	5.05e-05	0.000176	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CHRM3—nephrolithiasis	4.72e-05	0.000164	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APRT—nephrolithiasis	4.51e-05	0.000157	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	4.51e-05	0.000157	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SPP1—nephrolithiasis	4.42e-05	0.000153	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SPP1—nephrolithiasis	4.31e-05	0.00015	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SPP1—nephrolithiasis	4.22e-05	0.000147	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SPP1—nephrolithiasis	4.15e-05	0.000144	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SPP1—nephrolithiasis	4.13e-05	0.000144	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SPP1—nephrolithiasis	3.59e-05	0.000125	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SPP1—nephrolithiasis	3.46e-05	0.00012	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AQP1—nephrolithiasis	3.21e-05	0.000112	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SPP1—nephrolithiasis	3.06e-05	0.000106	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CHRM3—nephrolithiasis	2.91e-05	0.000101	CbGpPWpGaD
